Home / Pharmaceutical / Global Hospital Acquired Disease Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 To 2025

Global Hospital Acquired Disease Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 To 2025

Published: May 2016 | Published By: Acute Market Research

Hospital Acquired Disease Testing Market Growth, Future Prospects and Competitive Analysis, 2017 - 2025, the hospital acquired disease testing market was valued at USD 579.4 Mn in 2017, and is expected to reach USD 1,630.0 Mn by 2025, expanding at a CAGR of 5.4% from 2017 to 2025.

Market Insights

Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.

The global hospital acquired disease testing market is categorized into tests for hospital acquired pneumonia, urinary tract infection, surgical site infection, bloodstream infection, MRSA and others. Hospital acquired pneumonia and urinary tract infection together occupy more over 50% market share in 2015 with a larger set of revenue coming from urinary tract infection. The prevalence and morbidity associated with urinary tract infection is the highest among the other infection types and its diagnosis is the swiftest. It is anticipated that the dominance of this segment will continue through the forecast period 2016-2022. Other testing tools for surgical site infections and bloodstream infection are anticipated to undergo faster growth during the forecast period attributed by their alarming incidence in the emerging markets.

Geographically, North America is the largest regional market for hospital acquired disease testing, high number of hospital stays and the corresponding risk of contracting HAIs majorly determine the market size of this region. On the other hand, greater awareness and reducing the incidence of hospital readmission, along with the growing urgency to control hospital and healthcare costs contribute to the faster market growth rate of Asia-Pacific and Latin America hospital acquired disease testing markets.

In view of the market competition, this market is fragmented with a multitude of companies offering HAI testing tools. Some of the notable players in the hospital acquired disease testing market include Diatherix Corp, Roche, Cantel Medical Corporation, Qiagen, Cephid, bioMeriux and others.

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Hospital Acquired Disease Testing Market, by Infection Type, 2015 (USD Mn)
2.2 Hospital Acquired Disease Testing Market Share, by Geography, 2015 (Value %)

Chapter 3 Hospital Acquired Disease Testing Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players

Chapter 4 Global Hospital Acquired Disease Testing Market Analysis, by Infection Type
4.1 Preface
4.2 Pneumonia
4.3 Urinary Tract Infection
4.4 Blood Stream Infection
4.5 Surgical Site Infection
4.6 MRSA
4.7 Others

Chapter 5 Global Hospital Acquired Disease Testing Market, by Geography
5.1 Preface
5.2 North America
5.3 Europe
5.4 Asia-Pacific
5.5 Middle East and Africa (MEA)
5.6 Latin America

Chapter 6 Company Profiles
6.1 Becton Dickinson
6.1.1 Business Description
6.1.2 Financial Health and Budget Allocation
6.1.3 Product Positions/Portfolio
6.1.4 News Coverage
6.2 bioMerieux
6.2.1 Business Description
6.2.2 Financial Health and Budget Allocation
6.2.3 Product Positions/Portfolio
6.2.4 News Coverage
6.3 Cantel
6.3.1 Business Description
6.3.2 Financial Health and Budget Allocation
6.3.3 Product Positions/Portfolio
6.3.4 News Coverage
6.4 Cepheid
6.4.1 Business Description
6.4.2 Financial Health and Budget Allocation
6.4.3 Product Positions/Portfolio
6.4.4 News Coverage
6.5 Diatherix
6.5.1 Business Description
6.5.2 Financial Health and Budget Allocation
6.5.3 Product Positions/Portfolio
6.5.4 News Coverage
6.6 Qiagen
6.6.1 Business Description
6.6.2 Financial Health and Budget Allocation
6.6.3 Product Positions/Portfolio
6.6.4 News Coverage
6.7 Nordion
6.7.1 Business Description
6.7.2 Financial Health and Budget Allocation
6.7.3 Product Positions/Portfolio
6.7.4 News Coverage
6.8 Roche
6.8.1 Business Description
6.8.2 Financial Health and Budget Allocation
6.8.3 Product Positions/Portfolio
6.8.4 News Coverage
6.9 Others
6.9.1 Business Description
6.9.2 Financial Health and Budget Allocation
6.9.3 Product Positions/Portfolio
6.9.4 News Coverage

TABLE 1 Global Hospital Acquired Disease Testing Market, by Infection Type, 2015 – 2025 (USD Mn)
TABLE 2 Global Hospital Acquired Disease Testing Market, by Geography, 2015 – 2025 (USD Mn)
TABLE 3 North America Hospital Acquired Disease Testing Market, by Country, 2015 – 2025 (USD Mn)
TABLE 4 Europe Hospital Acquired Disease Testing Market, by Country, 2015 – 2025 (USD Mn)
TABLE 5 Asia-Pacific Hospital Acquired Disease Testing Market, by Country, 2015 – 2025 (USD Mn)

FIG. 1 Hospital Acquired Disease Testing: Market Segmentation
FIG. 2 Hospital Acquired Disease Testing Market, by Infection Type, 2015 (USD Mn)
FIG. 3 Hospital Acquired Disease Testing Market Share, by Geography, 2015 (Value %)
FIG. 4 Attractive Investment Proposition, Hospital Acquired Disease Testing Market, 2015
FIG. 5 Competitive Analysis: Fractal Map Investigation, by Key Market Players
FIG. 6 Global Hospital Acquired Pneumonia Testing Market, 2015 – 2025 (USD Mn)
FIG. 7 Global Hospital Acquired Urinary Tract Infection Testing Market, 2015 – 2025 (USD Mn)
FIG. 8 Global Hospital Acquired Blood Stream Infection Testing Market, 2015 – 2025 (USD Mn)
FIG. 9 Global Hospital Acquired Surgical Site Infection Market, 2015 – 2025 (USD Mn)
FIG. 10 Global MRSA Testing Market, 2015 – 2025 (USD Mn)
FIG. 11 Global Other Hospital Acquired Diseases Testing Market, 2015 – 2025 (USD Mn)
FIG. 12 U.S. Hospital Acquired Disease Testing Market, 2015 - 2025 (USD Mn)
FIG. 13 Canada Hospital Acquired Disease Testing Market, 2015 - 2025 (USD Mn)
FIG. 14 U.K. Hospital Acquired Disease Testing Market, 2015 - 2025 (USD Mn)
FIG. 15 Germany Hospital Acquired Disease Testing Market, 2015 - 2025 (USD Mn)
FIG. 16 Rest of Europe Hospital Acquired Disease Testing Market, 2015 - 2025 (USD Mn)
FIG. 17 Japan Hospital Acquired Disease Testing Market, 2015 - 2025 (USD Mn)
FIG. 18 China Hospital Acquired Disease Testing Market, 2015 - 2025 (USD Mn)
FIG. 19 Rest of Asia-Pacific Hospital Acquired Disease Testing Market, 2015 - 2025 (USD Mn)
FIG. 20 Middle East and Africa Hospital Acquired Disease Testing Market, 2015 - 2025 (USD Mn)
FIG. 21 Latin America Hospital Acquired Disease Testing Market, 2015 - 2025 (USD Mn)

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +